Skip to main content

Table 3 Subgroup analysis results by chemotherapy, baseline FPG and NLR

From: Serum gamma-glutamyltransferase and the overall survival of metastatic pancreatic cancer

Stratification variable Stratum Elevated serum GGT (> 48 U/L)
Adjusted HR (95% CI) Interaction
p-value
Palliative chemotherapy Yes 1.70 (1.16, 2.51) a 0.84
No 1.61 (1.10, 2.34) a
Baseline NLR ≥ 4.46 1.38 (0.95, 2.00) b 0.91
<  4.46 1.42 (0.99, 2.03) b
Baseline FPG ≥ 7.0 mmol/L 1.31 (0.90, 1.92) c 0.07
<  7.0 mmol/L 2.14 (1.48, 3.09) c
  1. a Adjusted for age at diagnosis, baseline NLR, baseline FPG
  2. b Adjusted for age at diagnosis, palliative chemotherapy, baseline FPG
  3. c Adjusted for age at diagnosis, palliative chemotherapy, baseline NLR
\